Related Experiment Video
Updated: May 31, 2026

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Published on: August 11, 2014
When more target antigen expression is less
1Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Hospices Civils de Lyon, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France.
Abstract:
Resistance to antibody drug conjugates (ADCs) may be due to low target antigen expression resulting in reduced intracellular payload concentration. In this issue of Cancer Cell, Wang et al. show that increased target antigen NECTIN4 expression is associated with reduced NECTIN4-ADC internalization and enhanced extracellular ADC release in a resistant tumor cell subpopulation.
Insights
Resistance to antibody drug conjugates (ADCs) can arise from low target antigen expression. This study reveals that increased NECTIN4 expression paradoxically reduces NECTIN4-ADC internalization and increases extracellular release in resistant tumors.
Area of Science:
- Oncology
- Molecular Biology
- Drug Development
Background:
- Antibody drug conjugates (ADCs) are crucial cancer therapeutics.
- Resistance to ADCs is a significant clinical challenge.
- Low target antigen expression is a known mechanism of ADC resistance.
Purpose of the Study:
- To investigate the role of target antigen expression in ADC resistance.
- To elucidate the mechanisms underlying resistance to NECTIN4-targeted ADCs.
- To identify novel strategies for overcoming ADC resistance.
Main Methods:
- Analysis of NECTIN4 expression in resistant tumor cell subpopulations.
- Assessment of NECTIN4-ADC internalization and payload delivery.
- Quantification of extracellular ADC release.
Main Results:
- Increased NECTIN4 expression was observed in a resistant tumor cell subpopulation.
- Higher NECTIN4 levels correlated with reduced NECTIN4-ADC internalization.
- Enhanced extracellular release of NECTIN4-ADCs was detected in resistant cells.
Conclusions:
- Contrary to expectations, elevated NECTIN4 expression can contribute to ADC resistance.
- This resistance mechanism involves impaired ADC internalization and increased release.
- Understanding this phenomenon is critical for optimizing ADC therapy.
More Related Videos
08:10Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
Published on: November 28, 2018
09:15Identification of Rare Antigen-Specific T Cells from Mouse Lungs with Peptide:Major Histocompatibility Complex Tetramers
Published on: July 19, 2024
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Affinity and Avidity
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Spare Receptors
Cell-mediated Immune Responses